Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 69434-007

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 69434-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhejiang Yongtai Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural (Rosuvastatintablet 01)

Chemical structure of rosuvastatin calcium, the active ingredient in Rosuvastatin Calcium tablets. The diagram depicts the molecular arrangement including fluorophenyl, sulfonamide, hydroxyl groups, and calcium ion components.*

FDA Label Image

Figure_1_time (Rosuvastatintablet 02)

A cumulative incidence graph depicting event rates over approximately 5 years for rosuvastatin calcium (Rosuva) versus placebo. The y-axis represents cumulative incidence percentage, and the x-axis shows years. The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) with P<0.001, indicating statistical comparison between groups. The number at risk for each group over time is listed below the graph.*

FDA Label Image

Figure_2-major (Rosuvastatintablet 03)

A data table presenting the number of clinical events comparing Rosuvastatin Calcium 20 mg with placebo 20 mg across several cardiovascular endpoints. The table includes event counts, rates per 1000 patient-years, hazard ratios with 95% confidence intervals, and p-values, along with a hazard ratio forest plot illustrating treatment effects on outcomes such as primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatintablet 04)

A box-and-whisker plot comparing the percent change from baseline in LDL-C levels for four statin drugs: Rosuvastatin (Crestor), Atorvastatin, Simvastatin, and Pravastatin. Each drug has data for different dose strengths (mg). The vertical axis shows percent change, ranging from 0 to -75%, with box plots indicating median, interquartile range, and variability of LDL-C reduction at each dose.*

FDA Label Image

Rosuvastatin Tablet_5mg (Rosuvastatintablet 5mg 90s)

Text panel from Rosuvastatin Tablets, USP 5 mg pharmaceutical labeling. It includes recommended dosage notes, storage instructions, warnings, manufacturer details (Zhejiang Yongtai Pharmaceutical Co., Ltd.), and barcode and QR code placeholders for GTIN, lot, expiration, and serial number. The panel specifies 90 tablets and Rx only status.*

FDA Label Image

Rosuvastatin Tablet_10mg (Rosuvastatintablet 10mg 90s)

Label for Rosuvastatin Tablets, USP 10 mg, containing 90 tablets. The product is manufactured by Zhejiang Yongtai Pharmaceutical Co., Ltd. The label includes dosage information, storage instructions, a barcode, and a QR code with GTIN, lot, expiration, and serial numbers. It specifies Rx only and storage conditions.*

FDA Label Image

Rosuvastatin Tablet_20mg (Rosuvastatintablet 20mg 90s)

Label for Rosuvastatin Tablets, USP 20 mg, film-coated tablets. The label shows the manufacturer as Zhejiang Yongtai Pharmaceutical Co., Ltd. It specifies a package size of 90 tablets and includes storage instructions and a warning to keep out of reach of children. The label also features the NDC code 69434-007-02 and a barcode.*

FDA Label Image

Rosuvastatin Tablet_40mg (Rosuvastatintablet 40mg 30s)

Label for Rosuvastatin Tablets, USP 40 mg, film-coated tablets in a package of 30 tablets. The label includes storage instructions, manufacturer Zhejiang Yongtai Pharmaceutical Co., Ltd., and a barcode. The product is prescription-only and includes a QR code with GTIN, lot, expiration, and serial number data fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.